Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Revenue: 2021-2024

Historic Revenue for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to $13.3 million.

  • Abivax's Revenue fell 21899.29% to -$7.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$13.0 million, marking a year-over-year decrease of 164.16%. This contributed to the annual value of $13.3 million for FY2024, which is 167.56% up from last year.
  • As of FY2024, Abivax's Revenue stood at $13.3 million, which was up 167.56% from $5.0 million recorded in FY2023.
  • In the past 5 years, Abivax's Revenue ranged from a high of $14.2 million in FY2021 and a low of $4.8 million during FY2022.
  • In the last 3 years, Abivax's Revenue had a median value of $5.0 million in 2023 and averaged $7.7 million.
  • In the last 5 years, Abivax's Revenue tumbled by 65.87% in 2022 and then spiked by 167.56% in 2024.
  • Yearly analysis of 4 years shows Abivax's Revenue stood at $14.2 million in 2021, then crashed by 65.87% to $4.8 million in 2022, then grew by 2.93% to $5.0 million in 2023, then soared by 167.56% to $13.3 million in 2024.